Participant flow

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy · Source last updated 2022-06-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Radiation therapy (64.8 Gy) + bicalutamide (150 mg daily 2 years)

   id

   FG000

   title

   Bicalutamide

2. description

   Radiation therapy (64.8 Gy) + placebo (daily 2 years)

   id

   FG001

   title

   Placebo

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         1

      type

      Withdrawal by Subject

   2. reasons

      1. group Id

         FG000

         num Subjects

         44

      2. group Id

         FG001

         num Subjects

         34

      type

      Protocol Violation

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         421

      2. group Id

         FG001

         num Subjects

         419

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         376

      2. group Id

         FG001

         num Subjects

         384

      comment

      Subjects with data available for the primary analysis are considered to have completed the study.

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         45

      2. group Id

         FG001

         num Subjects

         35

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice